50742-404 : Topotecan 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 50742-404
Labeler: Ingenus Pharmaceuticals, LLC
Product Type: Human Prescription Drug
Drug Name:  Topotecan
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA206962
Rev. Date: 


NDC Package Codes:

  • 50742-404-01: 4 ML IN 1 VIAL (50742‑404‑01)

Active Ingredients:

  • Topotecan Hydrochloride

Dosage Strength:

  • 4 mg/4mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0409-0302 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0703-4714 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc.
  • 16729-243 Topotecan 1 mg/ml Intravenous Injection by Accord Healthcare Inc.
  • 25021-236 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Sagent Pharmaceuticals
  • 66758-051 Topotecan 1 mg/ml Intravenous Injection by Sandoz Inc
  • 67457-662 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Mylan Institutional LLC
  • 71288-127 Topotecan 4 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50742-404 QR Code

< Prev: 50742-402Next: 50742-405 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.